- Home
- NINE vs PASG Comparison
NINE vs PASG Comparison
Compare NINE & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NINE
- PASG
- Stock Information
- Founded
- NINE 2011
- PASG 2017
- Country
- NINE United States
- PASG United States
- Employees
- NINE N/A
- PASG N/A
- Industry
- NINE Oilfield Services/Equipment
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- NINE Energy
- PASG Health Care
- Exchange
- NINE Nasdaq
- PASG Nasdaq
- Market Cap
- NINE 50.4M
- PASG 42.2M
- IPO Year
- NINE 2018
- PASG 2020
- Fundamental
- Price
- NINE $1.26
- PASG $0.54
- Analyst Decision
- NINE
- PASG Strong Buy
- Analyst Count
- NINE 0
- PASG 1
- Target Price
- NINE N/A
- PASG $13.00
- AVG Volume (30 Days)
- NINE 1.3M
- PASG 234.7K
- Earning Date
- NINE 10-31-2024
- PASG 11-13-2024
- Dividend Yield
- NINE N/A
- PASG N/A
- EPS Growth
- NINE N/A
- PASG N/A
- EPS
- NINE N/A
- PASG N/A
- Revenue
- NINE $556,751,000.00
- PASG N/A
- Revenue This Year
- NINE N/A
- PASG N/A
- Revenue Next Year
- NINE $3.95
- PASG N/A
- P/E Ratio
- NINE N/A
- PASG N/A
- Revenue Growth
- NINE N/A
- PASG N/A
- 52 Week Low
- NINE $0.75
- PASG $0.45
- 52 Week High
- NINE $3.26
- PASG $1.79
- Technical
- Relative Strength Index (RSI)
- NINE 56.34
- PASG 43.06
- Support Level
- NINE $1.10
- PASG $0.45
- Resistance Level
- NINE $1.29
- PASG $0.68
- Average True Range (ATR)
- NINE 0.17
- PASG 0.06
- MACD
- NINE 0.01
- PASG -0.01
- Stochastic Oscillator
- NINE 49.00
- PASG 37.12
About NINE Nine Energy Service Inc.
Nine Energy Service Inc is a North American onshore completion and production services provider. It targets unconventional oil and gas resource development. It operates in one segment, Completion Solutions. The Completion Solutions segment offers cementing services; completion tools, including liner hangers and accessories, frac sleeves, fully composite frac plugs, and specialty open hole float equipment and centralizers and other services. It operates in the U.S, Canada, and other countries where majority of the revenue is generated from the United States.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.